Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.0110+0.0010 (+10.00%)
At close: 05:04PM SGT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-2,905
-2,488
-9,374
-5,984
-4,651
-
Depreciation & amortisation
181
241
1,183
1,252
996.335
-
Stock-based compensation
-
0
-67
106
1,368
-
Change in working capital
136
-10
177
-390
-871.331
-
Inventory
31
-139
115
-394
-785.148
-
Other working capital
-2,282
-1,966
-3,157
-5,202
-2,881
-
Other non-cash items
98
80
138
146
707.012
-
Net cash provided by operating activities
-2,282
-1,966
-3,064
-4,641
-2,431
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-93
-561
-449.448
-686.132
Acquisitions, net
-
-
-
0
-89.979
0
Other investing activities
-
-2,689
98
-300
-
-
Net cash used for investing activities
-2,139
-2,689
5
-860
-539.427
-
Net change in cash
-3,684
-4,855
1,123
-6,647
4,527
-
Cash at beginning of period
3,830
5,029
3,960
10,669
6,030
-
Cash at end of period
146
183
5,029
3,960
10,669
-
Free cash flow
Operating cash flow
-2,282
-1,966
-3,064
-4,641
-2,431
-
Capital expenditure
-
-
-93
-561
-449.448
-686.132
Free cash flow
-2,282
-1,966
-3,157
-5,202
-2,881
-